Alnylam Pharmaceuticals Inc. (ALNY) is a biopharmaceutical company focused on developing RNA interference therapeutics for genetically defined diseases. A mouthful to say -- and above my pay grade in understanding -- but the charts are interesting.
More from Investing
There has been some selling pressure of late, but it is not correlated and is trapping overzealous bears.
Interpreting the flow of capital in theory, or at least historically, for equities is quite simple. It's about growth, or the lack thereof.
Here we'll look at the big picture, as we've recently seen the precious metals soar, bond yields break to new lows, and the dollar slide.
These familiar names are displaying both technical and quantitative deterioration.